Literature DB >> 16849532

Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.

Mallory S Lutz1, Robert D Burk.   

Abstract

Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, occurs in the majority of renal clear cell carcinomas (RCC). VHL's function, regulating the degradation of hypoxia-inducible factor alpha (HIFalpha) subunits, explains the angiogenic nature of these tumors, but not tumor initiation. Because the development of renal cysts precedes tumor formation, and because the dysfunction of primary cilium is a common pathogenic mechanism in polycystic kidney diseases, we determined whether kidney-derived VHL- cells required VHL for the generation of cilium. Ectopic expression of VHL in RCC(VHL-) cells induced increased polarization and primary cilium formation. Cilium formation correlated directly with the expression of both wild-type VHL isoforms and a VHL mutant not associated with RCC development, whereas expression of RCC-associated VHL mutants did not support ciliogenesis. Requirement of VHL for ciliogenesis was independent of HIFalpha abundance. These data indicate separable independent functions for VHL (HIFalpha degradation and differentiation) and suggest a mechanism whereby disruption of both functions is required for renal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849532     DOI: 10.1158/0008-5472.CAN-06-0501

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

Review 1.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

2.  Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation.

Authors:  Qingzhou Ji; Robert D Burk
Journal:  Biochem Cell Biol       Date:  2008-06       Impact factor: 3.626

3.  Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.

Authors:  Bjoern Buchholz; Gunnar Schley; Diana Faria; Sven Kroening; Carsten Willam; Rainer Schreiber; Bernd Klanke; Nicolai Burzlaff; Jonathan Jantsch; Karl Kunzelmann; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

Review 4.  The perennial organelle: assembly and disassembly of the primary cilium.

Authors:  E Scott Seeley; Maxence V Nachury
Journal:  J Cell Sci       Date:  2010-02-15       Impact factor: 5.285

5.  Drosophila VHL tumor-suppressor gene regulates epithelial morphogenesis by promoting microtubule and aPKC stability.

Authors:  Serena Duchi; Luca Fagnocchi; Valeria Cavaliere; Anita Hsouna; Giuseppe Gargiulo; Tien Hsu
Journal:  Development       Date:  2010-05       Impact factor: 6.868

6.  A novel VHLα isoform inhibits Warburg effect via modulation of PKM splicing.

Authors:  Yanbin Liu; Haixia Yang; Lin Li; She Chen; Feifei Zuo; Liang Chen
Journal:  Tumour Biol       Date:  2016-07-29

7.  Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia.

Authors:  E Scott Seeley; Catherine Carrière; Tobias Goetze; Daniel S Longnecker; Murray Korc
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 8.  Regulating the transition from centriole to basal body.

Authors:  Tetsuo Kobayashi; Brian D Dynlacht
Journal:  J Cell Biol       Date:  2011-05-02       Impact factor: 10.539

9.  Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression.

Authors:  Michael S Wiesener; Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  J Mol Med (Berl)       Date:  2009-07-24       Impact factor: 4.599

10.  Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes.

Authors:  Valentina Bangiyeva; Ava Rosenbloom; Ashlynn E Alexander; Bella Isanova; Timothy Popko; Alan R Schoenfeld
Journal:  BMC Cancer       Date:  2009-07-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.